Showing results (211-220 of 221) with videos related to

Sort By:
Pageof 23
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2018
Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled TrialAnthony T C Chan, Edwin P Hui, Roger K C Ngan, et al.
Asia-Pacific Journal of Clinical Oncology|April 17, 2024
Management of advanced prostate cancer in the Asia-Pacific region: Summary of the Asia-Pacific Advanced Prostate Cancer Consensus Conference 2023Edmund Chiong, Declan G Murphy, Nicholas Buchan, et al.
NEJM Evidence|February 6, 2024
Plasma Epstein-Barr Virus DNA and Risk of Future Nasopharyngeal CancerK C Allen Chan, W K Jacky Lam, Ann King, et al.
Seminars in Hematology|December 6, 2001
Use of recombinant factor VIIa (NovoSeven) in patients with Glanzmann thrombastheniaM C Poon, R d'Oiron, I Hann, et al.
JCO Precision Oncology|June 14, 2023
Consensus Statements on Precision Oncology in the China Greater Bay AreaTai-Chung Lam, William Chi-Shing Cho, Joseph Siu-Kie Au, et al.
European Urology|February 1, 2020
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019Silke Gillessen, Gerhardt Attard, Tomasz M Beer, et al.
European Urology|April 8, 2022
What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021Fabio Turco, Andrew Armstrong, Gerhardt Attard, et al.
European Urology|April 22, 2022
Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021Silke Gillessen, Andrew Armstrong, Gert Attard, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 2023
Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022Silke Gillessen, Alberto Bossi, Ian D Davis, et al.
European Urology|December 9, 2022
Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022Silke Gillessen, Alberto Bossi, Ian D Davis, et al.
Pageof 23